CURANEX PHARMACEUTICALS INC (CURX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$5.05+6.54%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CURX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
CURX — capital allocation — Material
Dated 2026-08-17
Material Modification to Rights of Security Holders. The information set forth in
Why it matters: If revenue growth in the health care sector picks up, it could benefit CURANEX.
Supportive ifHealth care sector revenue growth speeds up to 9% or more.
Worry ifSector revenue growth keeps slowing down below current levels.
Why it matters: If sector revenue growth slows, it could impact CURX's performance. CURX is already facing challenges.
Worry ifSector revenue growth reported below its median for the first time in years.
Less concerning ifSector revenue growth is still above average. This shows it is strong.
Why it matters: A significant acquisition could drive growth and change CURX's financial outlook. Investors will look for signs of strategic expansion.
Supportive ifA press release announcing a completed M&A deal valued at over $50 million.
Worry ifNo M&A activity announced by the end of the year.
Why it matters: The earnings report will show if CURX can improve its financial situation. Investors will look for signs of recovery.
Watch forThe earnings report shows smaller losses. It also shows a way to make money.
Also watch forThe earnings report shows ongoing losses. There is no clear plan to recover.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$262 on $10,000 · ±2.6% | How much price usually moves either way. |
| Bad day | $1,128 loss on $10,000 · 11.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,800 loss on $10,000 · 98.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Strong capital management is crucial as CURX faces ongoing losses. This will indicate financial health.
Worry ifA report shows CURX's operating income is better or losses are smaller.
Less concerning ifA big rise in losses or bad money management choices.
Why it matters: M&A activity could drive growth for CURX. Investors want to see progress in this area.
Supportive ifA press release says there is a signed deal for a big acquisition.
Worry ifNo announcements or progress on M&A activity over the next quarter.
Why it matters: Managing money well is key as CURX has ongoing losses. Good spending can help growth.
Supportive ifA report shows better financial controls or a successful money raise.
Worry ifOngoing losses with no new money management plans.
Why it matters: Stable leaders are important during CURX's tough times. Changes may hurt investor trust.
Watch forA public statement or press release confirms CEO Jun Liu is still leading.
Also watch forAnnouncement of a leadership change or departure of CEO Jun Liu.